Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Evidence based assessment of genomics in tic disorders in China

Analysis Of The Btbd9 And Htr2c Variants In Chinese Han Patients With Tourette Syndrome

Whole-exome sequencing identifies high-confidence genes for tic disorders in a Chinese Han population

Mutation screening of the HTR2B gene in patients with Tourette syndrome.

Mitochondrial DNA Variant Spectrum and the Association with Chronic Tic Disorders

Clinical management of children with tic disorder: insights from therapeutic visits in China—a real-world study

Neuropsychiatric comorbidities and associated factors in 182 Chinese children with tic disorders

Mitochondrial tRNA mutations in Chinese children with tic disorders

Candidate transmission disequilibrium analysis for quantitative traits in tourette syndrome in a chinese family trio sample

Genome-Wide Association Study Meta-Analysis of 9619 Cases With Tic Disorders

A Whole-Exome Sequencing Study of Tourette Disorder in a Chinese Population.

Association study of DRD4 exonⅢ48 bp variable number of tandem repeats polymorphism and tic disorder

Evidence-based evaluation of drug gene studies in Chinese patients with epilepsy

[Transmission Disequilibrium Test of DRD4 Exon III 48bp Variant Number Tandem Repeat Polymorphism and Tic Disorder].

Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in China

Acupuncture and other traditional Chinese medicine therapies in the treatment of children's tic syndrome: A network meta-analysis

Trends and quality assessment of randomized controlled trials of western medicine for tic disorders in China

Changes of Cytokines in Children With Tic Disorder

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

Advances in Molecular Genetic Studies of Attention Deficit Hyperactivity Disorder in China.

Family study of tic disorders